Home > Boards > US Listed > Electronics and components > Acacia Research-Acacia Technologies (ACTG)

Consecutive quarters of poor performance has had a

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
investora2z Member Profile
 
Followed By 9
Posts 602
Boards Moderated 0
Alias Born 02/08/13
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/25/2020 6:09:16 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 11/24/2020 6:03:37 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 11/19/2020 6:01:07 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/9/2020 5:08:41 PM
Acacia Research Reports Third Quarter 2020 Financial Results Business Wire - 11/9/2020 8:20:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2020 8:19:40 AM
Acacia Research to Release Third Quarter Financial Results Business Wire - 10/26/2020 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/20/2020 4:00:54 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 5:19:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2020 8:00:43 AM
Acacia Research Reports Second Quarter 2020 Financial Results Business Wire - 8/10/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/3/2020 4:31:53 PM
Acacia Research to Release Second Quarter Financial Results Business Wire - 7/29/2020 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/20/2020 2:02:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/7/2020 4:21:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2020 4:10:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2020 5:30:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2020 4:30:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2020 4:30:16 PM
Acacia Agrees to Acquire Portfolio of Life Science Assets for £223.9 million Business Wire - 6/5/2020 7:00:00 AM
Acacia Research Enhances Senior Management Team, Names Richard Rosenstein as CFO, Meredith Simmons as General Counsel Business Wire - 6/5/2020 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2020 5:27:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2020 5:05:56 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/4/2020 4:26:53 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/4/2020 4:24:46 PM
investora2z   Saturday, 11/30/13 06:32:21 AM
Re: None
Post # of 106 
Consecutive quarters of poor performance has had a decisive negative impact on the stock. The break below $20, and now below $15 indicates that there could be more pain in the offing. The stock needs to bounce immediately with good volumes, otherwise it may go down by another 10%. The main problem is the unpredictability in the earnings which makes it difficult to take a call on the future valuations. The fluctuations in the top line and the bottom line have decreased the faith of the investors over the last few quarters. The stock is now one third of its peak value in September 2011. The revenue stream is not diversified and there is excessive dependence on a few licensees. Even other similar sized companies may have a similar problem, but it is important for Acacia to do something about it fast. Lawsuits outcomes are unpredictable, and many companies in the sector are making efforts to diversify the IPR portfolio and focus on licensing revenues to get regular inflow. Marathon Patents Group (MARA) is attempting a balance between diversified licensing revenue stream and enforcement through litigation. Zacks now has a strong sell rating on Acacia, and the full year EPS for 2013 is estimated at 33 cents which indicates that the valuations are likely to remain high. The counter lawsuit by Microsoft (MSFT) has also had an impact on the sentiments. Microsoft has accused Acacia of claiming payments based on litigation tactics rather than demanding payments based on the actual valuation of its patents. The good part is that the company is debt free and has a huge amount of cash. However, the recently announced repurchase program will lead to some depletion over the next few quarters. The program is for purchase in the aggregate up to $70 million of its common stock through the period ending May 14, 2014.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences